Evidence map›Paper›PMID 39843565›Full record

ArticleOncogene2025

Correction: BEX4 inhibits the progression of clear cell renal cell carcinoma by stabilizing SH2D4A, which is achieved by blocking SIRT2 activity.

Ziyao Li, Shiyong Xin, Liqun Huang, Ye Tian, Weihua Chen, Xiang Liu, Bowen Ye, Rong Bai, Guosheng Yang, Wenwen Wang and 1 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Oncogene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Ziyao Li *Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Shiyong Xin *Department of Urology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
Liqun Huang *Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Ye TianDepartment of Urology, Guizhou Provincial People's Hospital, Guiyang, China.
Weihua ChenDepartment of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Xiang LiuDepartment of Urology, Putuo People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Bowen YeDepartment of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Rong BaiDepartment of Pharmacy, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Guosheng YangDepartment of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China. 2008yangguosheng@sina.com.
Wenwen WangDepartment of Biotherapy, Zhongshan Hospital, Fudan University, Shanghai, China. www0228@126.com.
Lin YeDepartment of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China. ericyelin@tongji.edu.cn.ORCID http://orcid.org/0000-0002-3304-4558

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39843565

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.